mTOR inhibitor therapy for patients with carcinoid

Lancet. 2011 Dec 10;378(9808):1978-1980. doi: 10.1016/S0140-6736(11)61789-3. Epub 2011 Nov 25.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Carcinoid Tumor / drug therapy*
  • Everolimus
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Malignant Carcinoid Syndrome / drug therapy*
  • Octreotide / therapeutic use*
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Immunosuppressive Agents
  • Everolimus
  • Octreotide
  • Sirolimus